Effect of homologous recombination deficient (HRD) breast cancers on a distinct immune marker phenotype by comprehensive genomic and immune profiling (CGIP) | Labcorp Oncology Skip to main contentScroll Back to Top
Effect of homologous recombination deficient (HRD) breast cancers on a distinct immune marker phenotype by comprehensive genomic and immune profiling (CGIP)
Poster
Effect of homologous recombination deficient (HRD) breast cancers on a distinct immune marker phenotype by comprehensive genomic and immune profiling (CGIP)
Heidi Chwan Ko, Sarabjot Pabla, Mary K Nesline, Kyle C Strickland, Rebecca A Previs, Zachary D Wallen, Shengle Zhang, Jeffrey M Conroy, Mark Sausen, Jennifer B Jackson, Kamal S Saini, Scott Wise, Taylor J Jensen, Venkataprasanth P. Reddy, Eric A Severson, Shakti Ramkissoon